Phaxiam

Phagos

The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.

Telum Therapeutics

Telum Therapeutics develops engineered phage lytic proteins to treat multidrug-resistant bacterial infections for patients with hospital-acquired and ventilator-associated pneumonia.

C10 PHARMA

This biopharmaceutical company develops novel antibiotics to treat life-threatening bacterial infections and combat antimicrobial resistance for patients with unmet medical needs.

BiomX

This clinical-stage biotechnology company develops natural and engineered bacteriophage cocktails to treat chronic bacterial infections and inflammatory diseases for healthcare providers and patients.

Clarametyx Biosciences

This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.

Felix Biotech

Felix Biotechnology develops engineered bacteriophage therapies to treat drug-resistant bacterial infections for patients with chronic diseases and partners in the skin care industry.

Omnix Medical

This biopharmaceutical company develops novel antibiotic agents for patients suffering from life-threatening, drug-resistant bacterial infections.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.